tiprankstipranks
Trending News
More News >
Rohto Pharmaceutical Co (JP:4527)
:4527

Rohto Pharmaceutical Co (4527) Revenue

Compare
1 Followers

Rohto Pharmaceutical Co Revenue

Rohto Pharmaceutical Co had a revenue of 86.81B in the quarter ending Dec 31, 2024, with 22.75%. This bring the company's revenue in the last twelve months to 295.57B, Decreased 4.79%. In the fiscal year ending Mar 31, 2025, Rohto Pharmaceutical Co had annual revenue of 308.63B with 13.95% growth.
Revenue (ttm)
295.57B
Revenue Growth
13.95%
P/S Ratio
1.54
Revenue/Employee
¥42,516,187
Employees
7,259
Market Cap
¥474.07B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
308.63B37.78B+13.95%
Mar 31, 2024
270.84B32.18B+13.48%
Mar 31, 2023
238.66B39.02B+19.54%
Mar 31, 2022
199.65B18.59B+10.27%
Mar 31, 2021
181.05B-7.32B-3.89%
Mar 31, 2020
188.38B4.70B+2.56%
Mar 31, 2019
183.67B11.88B+6.91%
Mar 31, 2018
171.79B17.20B+11.12%
Mar 31, 2017
154.60B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis